Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67


Immunoengineering in glioblastoma imaging and therapy.

Zanganeh S, Georgala P, Corbo C, Arabi L, Ho JQ, Javdani N, Sepand MR, Cruickshank K, Campesato LF, Weng CH, Hemayat S, Andreou C, Alvim R, Hutter G, Rafat M, Mahmoudi M.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Nov;11(6):e1575. doi: 10.1002/wnan.1575. Epub 2019 Aug 12. Review.


Gene Variants at Loci Related to Blood Pressure Account for Variation in Response to Antihypertensive Drugs Between Black and White Individuals.

Iniesta R, Campbell D, Venturini C, Faconti L, Singh S, Irvin MR, Cooper-DeHoff RM, Johnson JA, Turner ST, Arnett DK, Weale ME, Warren H, Munroe PB, Cruickshank K, Padmanabhan S, Lewis C, Chowienczyk P.

Hypertension. 2019 Sep;74(3):614-622. doi: 10.1161/HYPERTENSIONAHA.118.12177. Epub 2019 Jul 22.


What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study.

McGovern AP, Dennis JM, Shields BM, Hattersley AT, Pearson ER, Jones AG; MASTERMIND Consortium.

BMC Med. 2019 Apr 12;17(1):79. doi: 10.1186/s12916-019-1307-8.


Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data.

Dennis JM, Henley WE, Weedon MN, Lonergan M, Rodgers LR, Jones AG, Hamilton WT, Sattar N, Janmohamed S, Holman RR, Pearson ER, Shields BM, Hattersley AT; MASTERMIND Consortium.

Diabetes Care. 2018 Sep;41(9):1844-1853. doi: 10.2337/dc18-0344. Epub 2018 Aug 2.


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.


Do arterial stiffness and wave reflection underlie cardiovascular risk in ethnic minorities?

Faconti L, Nanino E, Mills CE, Cruickshank KJ.

JRSM Cardiovasc Dis. 2016 Aug 1;5:2048004016661679. doi: 10.1177/2048004016661679. eCollection 2016 Jan-Dec. Review.


Can arterial wave augmentation in young adults help account for variability of cardiovascular risk in different British ethnic groups?

Faconti L, Silva MJ, Molaodi OR, Enayat ZE, Cassidy A, Karamanos A, Nanino E, Read UM, Dall P, Stansfield B, Harding S, Cruickshank KJ.

J Hypertens. 2016 Nov;34(11):2220-6. doi: 10.1097/HJH.0000000000001066.


Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group.

N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19.


Detecting depression in pregnancy: validation of EPDS in British Pakistani mothers.

Husain N, Rahman A, Husain M, Khan SM, Vyas A, Tomenson B, Cruickshank KJ.

J Immigr Minor Health. 2014 Dec;16(6):1085-92. doi: 10.1007/s10903-014-9981-2.


Adherence to the USDA dietary recommendations for fruit and vegetable intake and risk of fatal stroke among ethnic groups: a prospective cohort study.

Sharma S, Pakserescht M, Cruickshank K, Green DM, Kolonel LN.

BMC Neurol. 2013 Sep 13;13:120. doi: 10.1186/1471-2377-13-120.


The predictive ability of blood pressure in elderly trial patients.

Carr MJ, Bao Y, Pan J, Cruickshank K, McNamee R.

J Hypertens. 2012 Sep;30(9):1725-33. doi: 10.1097/HJH.0b013e3283568a73.


Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction.

López-Andrés N, Rousseau A, Akhtar R, Calvier L, Iñigo C, Labat C, Zhao X, Cruickshank K, Díez J, Zannad F, Lacolley P, Rossignol P.

Hypertension. 2012 Aug;60(2):563-73. doi: 10.1161/HYPERTENSIONAHA.112.194407. Epub 2012 Jun 25.


Social stress and depression during pregnancy and in the postnatal period in British Pakistani mothers: a cohort study.

Husain N, Cruickshank K, Husain M, Khan S, Tomenson B, Rahman A.

J Affect Disord. 2012 Nov;140(3):268-76. doi: 10.1016/j.jad.2012.02.009. Epub 2012 May 17.


A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.

Hutchinson K, Cruickshank K, Wylie K.

Drug Saf. 2012 May 1;35(5):359-72. doi: 10.2165/11598150-000000000-00000. Review.


Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators.

Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29.


Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay.

Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, Wibberley C, Nuttall M, Mackway-Jones K.

J Am Coll Cardiol. 2011 Sep 20;58(13):1332-9. doi: 10.1016/j.jacc.2011.06.026. Erratum in: J Am Coll Cardiol. 2012 Sep 18;60(12):1122.


Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy.

ADVANCE Echocardiography Substudy Investigators; ADVANCE Collaborative Group.

J Hypertens. 2011 Jul;29(7):1439-47. doi: 10.1097/HJH.0b013e3283480fe9.


Diagnosing pulmonary embolism: a comparison of clinical probability scores.

Hogg K, Thomas D, Mackway-Jones K, Lecky F, Cruickshank K.

Br J Haematol. 2011 Apr;153(2):253-8. doi: 10.1111/j.1365-2141.2011.08575.x. Epub 2011 Mar 4.


Does high-sensitivity troponin measurement aid in the diagnosis of pulmonary embolism?

Hogg K, Haslam S, Hinchliffe E, Sellar L, Lecky F, Cruickshank K.

J Thromb Haemost. 2011 Feb;9(2):410-2. doi: 10.1111/j.1538-7836.2010.04153.x. No abstract available.


Statin cost-effectiveness in the United States for people at different vascular risk levels.

Heart Protection Study Collaborative Group.

Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):65-72. doi: 10.1161/CIRCOUTCOMES.108.808469. Epub 2009 Mar 5.


Supplemental Content

Loading ...
Support Center